News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Amazon's AWS posted 39% revenue growth and 38% operating margin, signaling continued cloud margin expansion and boosting Amazon's earnings outlook.
  • Astera Labs reported a blowout quarter with 153.7% revenue growth and raised Q4 guidance to $730–$750M, upping visibility for accelerator suppliers.
  • Wheaton Precious Metals and Pan American Silver trades push exposure to higher precious metals prices, prompting mid-term long ideas on both names.
  • TAT Technologies shows accelerating profit trends and bullish technicals, offering a tactical mid-term long on resilient MRO and OEM revenue conversion.
  • Analysts flag AMD's rally as vulnerable, recommending a mid-term short due to execution risks and valuation that assumes flawless execution.
  • AWS's margin beat increases pressure on peers' profitability and could re-rate large-cap tech multiples.

Latest Articles

Analysts Divided After Apple Unveils Foldable iPhone Duo and AI Push

Analysts Divided After Apple Unveils Foldable iPhone Duo and AI Push

Apple's 'Surprise and Shine' event introduced the Duo, the company's first foldable iPhone priced at $1,999, and highlighted new Siri AI work toward an agent in iOS 27. Analysts responded with mixed ratings: Citi and Goldman Sachs kept Buy stances citing potential for higher average selling prices, while Oppenheimer and Needham expressed caution on…

Biohaven Shares Drop After FDA Imposes Partial Hold on BHV-7000 Enrollment

Biohaven Shares Drop After FDA Imposes Partial Hold on BHV-7000 Enrollment

Biohaven Pharmaceutical shares tumbled in early trading after the FDA placed a partial clinical hold on new patient enrollment in BHV-7000 epilepsy trials, effective September 4, 2026. Existing patients will continue on treatment and a fully enrolled pivotal study remains on track for topline data in the second half of the year, but the enrollment …

CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder

CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder

CAMP4 Therapeutics Corporation has received regulatory authorization from the UK's MHRA to include UK sites in its global Phase 1/2 clinical trial of CMP-002, a potential disease-modifying antisense oligonucleotide treatment for SYNGAP1-related disorder. This follows recent clearances in Australia and Argentina, with the company on track to start t…

SKYX Signs Merger with Leading U.S. AI Smart Home Silicon Valley Backed Company Deako, Aiming to Lead the Smart Home, Builder & Hotel Markets with Their Combined Platform Technologies

SKYX Signs Merger with Leading U.S. AI Smart Home Silicon Valley Backed Company Deako, Aiming to Lead the Smart Home, Builder & Hotel Markets with Their Combined Platform Technologies

SKYX Platforms Corp. announced a merger with Deako Inc., a leading U.S. AI smart home and intelligent lighting company backed by Silicon Valley investors. This merger aims to combine SKYX's safe, plug & play AI platform with Deako's smart wall switch technologies, creating a comprehensive smart home solution for builders, hotels, and professional m…

Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York

Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York

Helus Pharma announced that its CEO Michael Halstead will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference. The company is focused on developing novel serotonergic agonists (NSAs) aimed at treating mental health conditions such as depression and anxiety, with two lead drug candidates in advanced clinical…

Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival

Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival

Immuneering Corporation announced that it will present new analyses at the AACR Conference demonstrating that their drug candidate, atebimetinib, exhibits a dual mechanism by both reducing tumor volume and preserving body mass in pancreatic cancer patients, potentially extending overall survival. The findings build on previous data showing 84% of t…

CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026

CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026

CervoMed announced that initial biomarker results from its Phase 2a clinical trial of neflamapimod in nonfluent variant primary progressive aphasia (nfvPPA) will be presented as a late-breaking oral session at the ISFTD 2026 meeting. The trial completed enrollment with 25 participants and evaluates safety and clinical effects of neflamapimod, a dru…

UK Confirms Nearly $40 Million Spend on SpaceX Military Satellite Services

UK Confirms Nearly $40 Million Spend on SpaceX Military Satellite Services

The British defence ministry disclosed it has spent close to $40 million on SpaceX satellite services, operating roughly 1,000 Starshield terminals and 500 Starlink terminals. The move followed SpaceX limiting Starlink to non-operational uses and led Britain to adopt the higher-priced, military-focused Starshield offering for encrypted, prioritized…

Airbnb: Growth Cycle Confirmed — a Tactical Long into $195

Airbnb: Growth Cycle Confirmed — a Tactical Long into $195

Airbnb looks to have entered the growth cycle we flagged in July. With Q2 revenue accelerating to $3.6B (up 17% YoY), high free cash flow ($4.86B trailing), and active product expansion—bolstered by AI—the risk/reward for a disciplined long is attractive. Entry $169.91, stop $150.00, target $195.00, horizon 180 trading days.

Algeria Cuts Diplomatic Relations With United Arab Emirates

Algeria Cuts Diplomatic Relations With United Arab Emirates

Algeria has severed diplomatic ties with the United Arab Emirates, with state media reporting the move came after authorities said they had exhausted all means to preserve bilateral relations. The government offered no specific justification. Algerian media earlier accused the UAE of trying to sow regional discord, and tensions have escalated since…

ResMed: Buy for Durable Growth and a Path Back to $280

ResMed: Buy for Durable Growth and a Path Back to $280

ResMed (RMD) combines recurring device revenue, expanding software-as-a-service for residential care, and accretive M&A to deliver steady growth. At roughly $220 today, the stock is trading at a forward multiple well below its recent historical average while delivering mid-teens EPS growth and healthy free cash flow. This trade idea outlines a long…

Burning Rock Reports Second Quarter 2026 Financial Results

Burning Rock Reports Second Quarter 2026 Financial Results

Burning Rock Biotech Limited reported its second quarter 2026 financial results, showing a 9.3% year-over-year decrease in total revenue to RMB134.7 million (US$19.9 million), driven by reduced pharma R&D services and central laboratory testing offset partially by growth in in-hospital sales. The company progressed in regulatory review for several …

Concorde International Group Announces Concorde Security as Official Security Partner of Hougang United FC

Concorde International Group Announces Concorde Security as Official Security Partner of Hougang United FC

Concorde International Group announced that its subsidiary, Concorde Security, will serve as the official security partner for Hougang United Football Club during the 2026/27 Singapore Premier League season. The partnership introduces Concorde's proprietary mobile security technologies, including the i-Facility Sprinter and i-FlexCam, to enhance se…

Southern Copper Plummets in Pre-Market Trade as Copper Sentiment Worsens

Southern Copper Plummets in Pre-Market Trade as Copper Sentiment Worsens

Southern Copper shares plunged 6.8% in pre-open trading to $195, moving the stock below its recent trading band though still well above its 52-week low of $97.90. The fall appears linked to a deterioration in commodity-market sentiment - most likely a pullback in copper spot prices driven by weakening demand expectations - and comes amid unresolved…